Combined ER/PR co-positivity enhances prognostic stratification within molecular subtypes of endometrial cancer
Journal of Gynecologic Oncology · 2026
DOI: 10.3802/jgo.2026.37.e61 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Ruxue Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Receptors, Progesterone, Receptors, Estrogen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Clinical Research Incubation Project, Beijing Chao-Yang Hospital, Capital Medical University.
Abstract (Originalsprache)
OBJECTIVE: To explore the prognostic value of combined estrogen receptor (ER)/progesterone receptor (PR) expression patterns within molecular subtypes of endometrial cancer (EC), particularly in the prognostically heterogeneous no specific molecular profile (NSMP) subtype. METHODS: A retrospective cohort study of 388 EC patients underwent next-generation sequencing-based molecular classification and ER/PR immunohistochemistry. ER/PR status was categorized as co-positive (coP), co-negative, or discordant. Multivariable Cox models and concordance index (C-index) analyses assessed disease-specific survival (DSS) and progression-free survival (PFS). RESULTS: ER/PR co-positivity independently predicted improved DSS overall (hazard ratio [HR]=0.143; 95% confidence interval [CI]=0.065, 0.314; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
- Department of Pathology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
- Department of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. hual_gyn@163.com.
ORCID-Profile: Ruxue Han, Yang Chen, Shuiqing Xu, Tingting Zhang, Xingran Jiang, Hua Li
Förderung
- National Natural Science Foundation of China
- Clinical Research Incubation Project, Beijing Chao-Yang Hospital, Capital Medical University
Zitieren
APA
Han, R., Chen, Y., Xu, S., Zhang, T., Jiang, X., & Li, H. (2026). Combined ER/PR co-positivity enhances prognostic stratification within molecular subtypes of endometrial cancer. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e61
Vancouver
Han R, Chen Y, Xu S, Zhang T, Jiang X, Li H. Combined ER/PR co-positivity enhances prognostic stratification within molecular subtypes of endometrial cancer. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e61
BibTeX
@article{Han2026,
author = {Han, Ruxue and Chen, Yang and Xu, Shuiqing and Zhang, Tingting and Jiang, Xingran and Li, Hua},
title = {Combined ER/PR co-positivity enhances prognostic stratification within molecular subtypes of endometrial cancer},
journal = {Journal of Gynecologic Oncology},
year = {2026},
doi = {10.3802/jgo.2026.37.e61}
}
EUVIMED